Headlands Technologies LLC Acquires 6,563 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Headlands Technologies LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 295.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,785 shares of the healthcare conglomerate's stock after purchasing an additional 6,563 shares during the quarter. Headlands Technologies LLC's holdings in UnitedHealth Group were worth $4,444,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also modified their holdings of UNH. Norges Bank purchased a new position in UnitedHealth Group in the fourth quarter valued at approximately $6,375,744,000. Raymond James Financial Inc. bought a new stake in shares of UnitedHealth Group in the 4th quarter worth about $1,914,740,000. Amundi increased its holdings in shares of UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock valued at $3,183,132,000 after acquiring an additional 2,991,470 shares during the last quarter. Proficio Capital Partners LLC raised its holdings in shares of UnitedHealth Group by 76,830.4% during the fourth quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate's stock worth $955,388,000 after purchasing an additional 1,886,186 shares during the period. Finally, Franklin Resources Inc. grew its holdings in shares of UnitedHealth Group by 10.7% during the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock valued at $4,514,178,000 after purchasing an additional 861,854 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Insider Activity

In related news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company's stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.33% of the company's stock.

UnitedHealth Group Price Performance

Shares of UNH stock traded up $0.49 during trading hours on Wednesday, reaching $523.61. The company's stock had a trading volume of 2,368,702 shares, compared to its average volume of 4,265,458. The firm's 50 day simple moving average is $509.06 and its 200-day simple moving average is $542.96. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $478.95 billion, a price-to-earnings ratio of 33.78, a PEG ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company's revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the prior year, the business earned $5.83 earnings per share. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's payout ratio is 54.19%.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. Oppenheimer upped their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a research report on Friday, December 6th. Piper Sandler reduced their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research note on Thursday, January 2nd. Barclays decreased their price objective on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research report on Friday, January 17th. Stephens raised their target price on UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a report on Thursday, December 5th. Finally, StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Twenty equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus target price of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.